LIVE
News CNBC

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising - CNBC

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising - CNBC

Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.

Novo Nordisk on Tuesday filed a lawsuit against Eli Lilly, alleging that its advertising campaigns for its blockbuster obesity and diabetes drugs are designed to mislead consumers about their superioโ€ฆ [+4666 chars]

Discussion (0)

No comments yet. Be the first to share your thoughts!

Join the Conversation

You need to be logged in to leave a comment.

Sign In Create Account